HB 1501-FN - AS INTRODUCED

2022 SESSION

22-2756

05/11

HOUSE BILL 1501-FN

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

SPONSORS: Rep. McBeath, Rock. 26; Rep. Van Houten, Hills. 45; Rep. Abel, Graf. 13

COMMITTEE: Commerce and Consumer Affairs

-----------------------------------------------------------------

ANALYSIS

This bill repeals a prospective modification of RSA 417-E:1, III(f), regarding insurance coverage for pediatric autoimmune neuropsychiatric disorders.  In 2024, the phrase "when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician" would have been removed from the statute.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

22-2756

05/11

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty Two

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1  Repeal; Pediatric Autoimmune Neuropsychiatric Disorders.  2019, 277:3, relative to a modification of insurance coverage for pediatric autoimmune neuropsychiatric disorders effective July 1, 2024, is repealed.

2  Effective Date.  This act shall take effect 60 days after its passage.

LBA

22-2756

11/23/21

HB 1501-FN- FISCAL NOTE

AS INTRODUCED

AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.

FISCAL IMPACT:      [ X ] State              [ X ] County               [ X ] Local              [    ] None

METHODOLOGY:

This bill repeals a prospective modification of RSA 417-E:1, III(f), regarding insurance coverage

for pediatric autoimmune neuropsychiatric disorders.  

The Insurance Department states this bill repeals the repeal of existing legislation that would be  effective on 7/1/2024 under current law.  The existing law mandates coverage for pediatric autoimmune neuropsychiatric disorders.  The law has been in effect for a short period and the Department has performed an analysis of claims.  However, the diagnosis code (D89.98) is not specific to just this patient population and cannot be relied upon to accurately identify claim costs therefore the impact of eliminating the repeal on claim costs and the insurance premium tax cannot be determined.  The Department noted the impact on claim costs would not necessarily inform the impact on premiums, or premium tax.  Issuers and purchasers may respond with premium increases, product design changes and buy-downs.  

AGENCIES CONTACTED:

Insurance Department